[1] Wearing SC, Hennig EM, Byrne NM, et al. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev. 2006;7(3):239-250.[2] Kock L, van Donkelaar CC, Ito K. Tissue engineering of functional articular cartilage: the current status. Cell Tissue Res. 2012;347(3):613-627.[3] Lim JY, Loiselle AE, Lee JS, et al. Optimizing the osteogenic potential of adult stem cells for skeletal regeneration. Orthop Res. 2011;29(11):1627-1633.[4] Tollervey JR, Lunyak VV. Adult stem cells: simply a tool for regenerative medicine or an additional piece in the puzzle of human aging? Cell Cycle. 2011;10(24):4173-4176.[5] Wang YT, Wu XT, Wang F. Regeneration potential and mechanism of bone marrow mesenchymal stem cell transplantation for treating intervertebral disc degeneration. J Orthop Sci. 2010;15(6):707-719.[6] Lee KS, Wilson JJ, Rabago DP, et al. Musculoskeletal applications of platelet-rich plasma: fad or future? AJR Am J Roentgenol. 2011;196(3):628-636.[7] Zhou HY, Wang C, Geng Z. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2011;15(24):4415-4418.周海洋,王宸,耿震.自体富含血小板血浆对兔骨折愈合的影响[J].中国组织工程研究与临床康复,2011,15(24):4415-4418.[8] Geng Z, Wang C, Zhou HY. Zhongguo Xiufu Chongjian Waikexue Zazhi. 2011;25(3):344-348.耿震,王宸,周海洋.富血小板血浆对肌腱愈合影响的实验研究[J].中国修复重建外科杂志, 2011,25(3):344-348.[9] Morizaki Y, Zhao C, An KN, et al. The effects of platelet-rich plasma on bone marrow stromal cell transplants for tendon healing in vitro. J Hand Surg Am. 2010;35(11):1833-1841.[10] Xie X, Wang Y, Zhao C, et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials. 2012;33(29):7008-7018.[11] Torigoe I, Sotome S, Tsuchiya A, et al. Bone regeneration with autologous plasma, bone marrow stromal cells, and porous beta-tricalcium phosphate in nonhuman primates. Tissue Eng Part A. 2009;15(7):1489-1499.[12] Ito K, Yamada Y, Nakamura S, et al. Osteogenic potential of effective bone engineering using dental pulp stem cells, bone marrow stem cells, and periosteal cells for osseointegration of dental implants. Int J Oral Maxillofac Implants. 2011;26(5): 947-954.[13] Cenni E, Perut F, Ciapetti G, et al. In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering. J Mater Sci Mater Med. 2009;20(1):45-50.[14] The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30. [15] Zhang J, Wang JH. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med. 2010;38(12):2477-2486.[16] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408.[17] Sánchez-González DJ, Méndez-Bolaina E, Trejo-Bahena NI. Platelet-rich plasma peptides: key for regeneration. Int J Pept. 2012;2012:532519. [18] Atik OS. Is the evidence behind platelet-rich plasma therapies strong enough? Eklem Hastalik Cerrahisi. 2012;23(1):1.[19] Niemeyer P, Fechner K, Milz S, et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials. 2010;31(13):3572-3579.[20] Hapa O, Cak?c? H, Kükner A, et al. Effect of platelet-rich plasma on tendon-to-bone healing after rotator cuff repair in rats: an in vivo experimental study. Acta Orthop Traumatol Turc. 2012;46(4):301-307.[21] Zhong W, Sumita Y, Ohba S, et al. In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One. 2012; 7(7): e40833. [22] Kon E, Filardo G, Di Martino A, et al. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):516-527. [23] Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1-9.[24] Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999;181(1):67-73.[25] Chen PM, Yen ML, Liu KJ, et al. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci. 2011;18(1):49.[26] Jaiswal N, Haynesworth SE, Caplan AI, et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64(2): 295-312.[27] Guo X, Huo R, Lü RR, et al. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2011,15(6):963-966.郭璇,霍然,吕仁荣,等.兔骨髓间充质干细胞培养及向成软骨细胞的诱导分化[J].中国组织工程研究与临床康复,2011,15(6): 963-966.[28] Su JM, Jin Y, Qu Q, et al. Jichu Yixue yu Linchuang. 2010; 30(5):520-523.苏金梅,金晔,曲强,等.骨髓间充质干细胞向软骨细胞分化过程中miR130a的表达[J].基础医学与临床,2010,30(5):520-523.[29] Fukumoto T, Sperling JW, Sanyal A, et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage. 2003;11(1): 55-64.[30] Eleswarapu SV, Leipzig ND, Athanasiou KA. Gene expression of single articular chondrocytes. Cell Tissue Res. 2007;327(1):43-54. [31] Wei Y, Zeng W, Wan R, et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater. 2012;23:1-12. |